Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$0.68 - $1.25 $49,065 - $90,193
72,155 Added 15.67%
532,691 $378,000
Q4 2022

Feb 13, 2023

BUY
$0.96 - $1.34 $146,731 - $204,812
152,845 Added 49.67%
460,536 $474,000
Q3 2022

Nov 10, 2022

BUY
$1.02 - $2.23 $16,267 - $35,566
15,949 Added 5.47%
307,691 $406,000
Q2 2022

Aug 12, 2022

SELL
$0.94 - $1.94 $4,534 - $9,358
-4,824 Reduced 1.63%
291,742 $301,000
Q1 2022

May 16, 2022

BUY
$1.54 - $3.71 $31,097 - $74,916
20,193 Added 7.31%
296,566 $583,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $39,301 - $59,561
15,233 Added 5.83%
276,373 $738,000
Q3 2021

Nov 12, 2021

BUY
$2.77 - $4.05 $128,021 - $187,178
46,217 Added 21.5%
261,140 $884,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $367,518 - $889,781
214,923 New
214,923 $824,000
Q2 2020

Aug 12, 2020

SELL
$0.39 - $0.69 $10,557 - $18,678
-27,070 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$0.56 - $1.62 $4,227 - $12,229
7,549 Added 38.67%
27,070 $17,000
Q4 2019

Feb 12, 2020

SELL
$0.83 - $1.3 $31,031 - $48,603
-37,387 Reduced 65.7%
19,521 $18,000
Q3 2019

Nov 12, 2019

SELL
$0.97 - $1.94 $27,929 - $55,858
-28,793 Reduced 33.6%
56,908 $56,000
Q2 2019

Aug 14, 2019

BUY
$1.81 - $2.45 $13,607 - $18,419
7,518 Added 9.62%
85,701 $175,000
Q1 2019

May 14, 2019

BUY
$2.3 - $3.27 $83,393 - $118,563
36,258 Added 86.48%
78,183 $191,000
Q4 2018

Feb 13, 2019

BUY
$2.49 - $4.54 $104,393 - $190,339
41,925 New
41,925 $109,000
Q3 2018

Nov 13, 2018

SELL
$3.4 - $4.84 $60,720 - $86,437
-17,859 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.03 - $4.98 $54,112 - $88,937
17,859 New
17,859 $73,000
Q1 2018

May 15, 2018

SELL
$2.48 - $3.21 $56,774 - $73,486
-22,893 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$2.43 - $3.54 $55,629 - $81,041
22,893
22,893 $61,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $610M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.